You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

CORPORATE

Coronavirus, from Plasma an anti Covid-19 treatment

Kedrion’s commitment to find a treatment from convalescent patient plasma

read more 

CORPORATE

Letter to patient associations and scientific organizations

Communication from Paolo Marcucci, Chairman & CEO of Kedrion

read more 
For more information please contact: pressoffice@kedrion.com